265 related articles for article (PubMed ID: 11798133)
1. Sjögren's syndrome: immunological response underlying the disease.
Brayer JB; Humphreys-Beher MG; Peck AB
Arch Immunol Ther Exp (Warsz); 2001; 49(5):353-60. PubMed ID: 11798133
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome.
Soyfoo MS; Steinfeld S; Delporte C
Oral Dis; 2007 Jul; 13(4):366-75. PubMed ID: 17577322
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
4. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.
van Blokland SC; Versnel MA
Clin Immunol; 2002 May; 103(2):111-24. PubMed ID: 12027416
[No Abstract] [Full Text] [Related]
6. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
8. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
9. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
11. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
12. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
[TBL] [Abstract][Full Text] [Related]
13. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG
J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330
[TBL] [Abstract][Full Text] [Related]
14. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
[TBL] [Abstract][Full Text] [Related]
15. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
van Blokland SC; van Helden-Meeuwsen CG; Wierenga-Wolf AF; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
Lab Invest; 2000 Apr; 80(4):575-85. PubMed ID: 10780673
[TBL] [Abstract][Full Text] [Related]
16. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
[TBL] [Abstract][Full Text] [Related]
17. Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice.
Hamano H; Saito I; Haneji N; Mitsuhashi Y; Miyasaka N; Hayashi Y
Eur J Immunol; 1993 Oct; 23(10):2387-91. PubMed ID: 8405038
[TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.
Li N; Shigihara T; Tzioufas AG; Notkins AL; Yoon JW; Jun HS
Arthritis Rheum; 2007 Jul; 56(7):2211-5. PubMed ID: 17599739
[TBL] [Abstract][Full Text] [Related]
19. Genetic dissociation of dacryoadenitis and sialadenitis in a Sjogren's syndrome mouse model with common and different susceptibility gene loci.
Kamao T; Miyazaki T; Soga Y; Komori H; Terada M; Ohashi Y; Nose M
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3257-65. PubMed ID: 19218603
[TBL] [Abstract][Full Text] [Related]
20. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
